Ignazia Prigione

Downregulation and/or Release of NKG2D Ligands as Immune Evasion Strategy of Human Neuroblastoma

Lizzia Raffaghello, Ignazia Prigione, Irma Airoldi et al. · Neoplasia · 2004 · 258 citations · Full text

Life Sciences, Immunology, Oncology +14

γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes

Irma Airoldi, Alice Bertaina, Ignazia Prigione et al. · Blood · 2015 · 235 citations · Full text

Life Sciences, Hematology, Immunology +16

Reciprocal Interactions Between Human Mesenchymal Stem Cells and <i>γδ</i> T Cells Or Invariant Natural Killer T Cells

Ignazia Prigione, Federica Benvenuto, Paola Bocca et al. · Stem Cells · 2008 · 154 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Neutrophils from patients with <i>TNFRSF1A</i> mutations display resistance to tumor necrosis factor–induced apoptosis: Pathogenetic and clinical implications

Andrea D’Osualdo, Francesca Ferlito, Ignazia Prigione et al. · Arthritis & Rheumatism · 2006 · 143 citations · Full text

Medicine, Immunology, Pathology +17

Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model

Paola Bocca, Emma Di Carlo, Ignazio Caruana et al. · OncoImmunology · 2017 · 119 citations · Full text

Medicine, Immunology, Oncology +17